Ancient naturopathic wisdom is becoming global practice worldwide as alternative medicines gain traction. One of the biggest reasons for its grow this the emerging idea of self-help. Therapies in alternative medicine are holistic, and emphasize the physical, mental, emotional, and spiritual aspects of the whole person. Some of the treatments are even preventive, driven by good health practices.
From acupuncture to ayurveda, including homeopathy, chiropractic, and osteopathic medicine, alternative medicine is all set to rejuvenate conventional medicines and offer low- to no-risk treatments. The global alternative medicines market is about to reach $694.22 billion by the end of 2030, growing at a CAGR of 25.1 percent.
To put the spotlight on key developments in the industry, Pharma Tech Outlook illustrates how patients are leveraging advanced alternative medicine to improve the quality of care. The edition also features thought-provoking articles from Carlos Pedraza, PhD, Director of CNS Biology at Alkermes; Alexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceuticals; and Erika Vento-Gaudens, Director, Global Clinical Trial Operations at Guardant Health. They shed light on innovation versus validation in early drug discovery, the importance of discovering medicines for the future, and the rise in outsourcing clinical trials.
In this edition of Pharma Tech Outlook, we also bring you the story of some of the top alternative medicine companies that help clients maximize the success of providing quality care with traditional practices. In the list, Kerala Ayurveda USA stands out for its ability to popularize the ancient natural system of medicine through its traditional wellness products and self-care programs that help clients heal and recover from within by improving their immune systems.
Through the following pages, we aim to shine a light on the innovative trends and latest developments in the alternative medicine sector. We would like to know your thoughts.
